Data / Form D filings / Amphix Bio, Inc.
Amphix Bio, Inc.: Form D filing
Amphix Bio, Inc., a biotechnology company in Chicago, IL, filed a Form D with the SEC in 2025. The latest, on December 19, 2025, reports $10.3 million sold of a $12.5 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 N. ABERDEEN ST., SUITE 900, Chicago, IL, 60642
- Phone
- (720) 840-7327
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2101704
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | New notice | $12,500,000 | $10,300,000 | $2,200,000 | 9 | Dec 4, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Samuel Stupp | Executive Officer, Director | |
| Kok-Wai Wong | Director | |
| Stephen R Wilson | Director | |
| John Potocsnak | Director | |
| Nicholas Sather | Executive Officer, Director |
Other biotechnology companies in Illinois that filed recently
- Neopenda, PBC $215,000 · Aug 27, 2026
- Auvi Labs, Inc. $442,352 · Aug 26, 2026
- Archean Sciences, Inc. $385,000 · Aug 13, 2026
Every Form D from the week of Dec 15, 2025 · All recent filings in Illinois · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Amphix Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.